Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum.

BACKGROUND: The efficacy of anti-malarial drugs is determined by the level of parasite susceptibility, anti-malarial drug bioavailability and pharmacokinetics, and host factors including immunity. Host immunity improves the in vivo therapeutic efficacy of anti-malarial drugs, but the mechanism and m...

Full description

Bibliographic Details
Main Authors:	Monatrakul, P, Mungthin, M, Dondorp, A, Krudsood, S, Udomsangpetch, R, Wilairatana, P, White, N, Chotivanich, K
Format:	Journal article
Language:	English
Published:	BioMed Central 2010

Similar Items

Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate.
by: Arreesrisom, P, et al.
Published: (2007)

Anti-malarial drugs: how effective are they against <it>Plasmodium falciparum </it>gametocytes?
by: Peatey Christopher L, et al.
Published: (2012-02-01)

Human saliva as a source of anti-malarial antibodies to examine population exposure to <it>Plasmodium falciparum</it>
by: West Sheila, et al.
Published: (2011-04-01)

<it>In vitro </it>activity of pyronaridine against <it>Plasmodium falciparum </it>and comparative evaluation of anti-malarial drug susceptibility assays
by: Pongratz Peter, et al.
Published: (2009-04-01)

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01)

<it>Ex vivo </it>susceptibility of <it>Plasmodium falciparum </it>isolates from Dakar, Senegal, to seven standard anti-malarial drugs
by: Pradines Bruno, et al.
Published: (2011-10-01)

Global gene expression profiling of <it>Plasmodium falciparum </it>in response to the anti-malarial drug pyronaridine
by: Chavalitshewinkoon-Petmitr Porntip, et al.
Published: (2011-08-01)

Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
by: Dao Ngoc Hien Tam, et al.
Published: (2020-08-01)

Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges
by: Dahal, P, et al.
Published: (2017)

Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort
by: Laochan, N, et al.
Published: (2015)

Malarial molecular chaperones of the Plasmodium falciparum infected erythrocyte
by: Day, J
Published: (2018)

Characterisation of the mediator complex in the malarial parasite Plasmodium falciparum
by: Uthra Balasubramaniyan Iyer
Published: (2018)

Risk factors for <it>Plasmodium falciparum </it>hyperparasitaemia in malarious children
by: Happi Christian T, et al.
Published: (2011-10-01)

A new double-antibody sandwich ELISA targeting <it>Plasmodium falciparum </it>aldolase to evaluate anti-malarial drug sensitivity
by: Brun Reto, et al.
Published: (2009-10-01)

Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India
by: Ramakanta Rana, et al.
Published: (2022-12-01)

Prevalence of molecular markers of anti-malarial drug resistance in <it>Plasmodium vivax </it>and <it>Plasmodium falciparum </it>in two districts of Nepal
by: Bygbjerg Ib C, et al.
Published: (2011-04-01)

Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019
by: Rathmes, G, et al.
Published: (2020)

Dynamics of anti-malarial antibodies in non-immune patients during and after a first and unique Plasmodium falciparum malaria episode
by: Zeno Bisoffi, et al.
Published: (2020-06-01)

QSAR study of amidino bis-benzimidazole derivatives as potent anti-malarial agents against plasmodium falciparum /
by: Worachartcheewan, Apilak, et al.

Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges
by: Prabin Dahal, et al.
Published: (2017-10-01)

Longitudinal <it>in vitro</it> surveillance of <it>Plasmodium falciparum</it> sensitivity to common anti-malarials in Thailand between 1994 and 2010
by: Parker Daniel, et al.
Published: (2012-08-01)

Validation of Plasmodium falciparum dUTPase as the target of 5′-tritylated deoxyuridine analogues with anti-malarial activity
by: Guiomar Pérez-Moreno, et al.
Published: (2019-12-01)

Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum
by: Rebecca Smith-Aguasca, et al.
Published: (2019-10-01)

Poisoning by anti-malarial drugs
by: David Tibbutt
Published: (2013-08-01)

ANTI-MALARIAL DRUG RESISTANCE
by: Yenni Yusuf
Published: (2014-05-01)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum.
by: Chotivanich, K, et al.
Published: (2012)

The role of anti-malarial drugs in eliminating malaria.
by: White, N
Published: (2008)

Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro <it>Plasmodium falciparum </it>susceptibility to standard anti-malarial drugs
by: Travers Dominique, et al.
Published: (2011-01-01)

Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs
by: Francis Tsombeng Foguim, et al.
Published: (2019-08-01)

The role of anti-malarial drugs in eliminating malaria
by: White Nicholas J
Published: (2008-12-01)

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
by: Francis Tsombeng Foguim, et al.
Published: (2020-06-01)

Docking of anti-malarial drug derivatives into Plasmodium Vivax dihydrofolate reductase /
by: Wong, Bing Ming, 1986-, et al.
Published: (2009)

Anti-malarial activity of geldanamycin derivatives in mice infected with <it>Plasmodium </it><it>yoelii</it>
by: Mout Rubul, et al.
Published: (2012-02-01)

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against <it>Plasmodium falciparum</it>
by: Pradines Bruno, et al.
Published: (2010-05-01)

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.
by: White, N, et al.
Published: (2009)

Differential Plasmodium falciparum surface antigen expression among children with Malarial Retinopathy
by: Abdi, A, et al.
Published: (2015)

The effect of mimicking febrile temperature and drug stress on malarial development
by: Adisakwattana Poom, et al.
Published: (2009-06-01)

Reflections on the 'discovery' of the anti-malarial qinghao
by: Hsu, E
Published: (2006)

Novel anti-malarial combinations and their toxicity.
by: Angus, B
Published: (2014)

Anti-malarial effect of gum arabic
by: Nasir Omaima, et al.
Published: (2011-05-01)